The Rapid Coronavirus Antibody Test: Can We Improve Accuracy?

The Rapid Coronavirus Antibody Test: Can We Improve Accuracy?

Bibliographic Details
Main Authors:	Ina P. Pavlova, Sujit S. Nair, Natasha Kyprianou, Ash K. Tewari
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-09-01
Series:	Frontiers in Medicine
Subjects:	SARS-CoV-2 antibodies neutralizing antibodies rapid tests lateral flow assays paper based analytical devices
Online Access:	https://www.frontiersin.org/article/10.3389/fmed.2020.00569/full

Similar Items

Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Serological Diagnostic Tests and Antibody Kinetics in Coronavirus Disease 2019 Patients
by: Choi, H.-W, et al.
Published: (2022)

Development of Coronavirus Treatments Using Neutralizing Antibodies
by: Saman Fouladirad, et al.
Published: (2021-01-01)

Adaptation of the MTT assay for detection of neutralizing antibodies against the SARS-CoV-2 virus
by: A. V. Gracheva, et al.
Published: (2021-07-01)

Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies
by: Anwar M. Hashem, et al.
Published: (2020-12-01)

Mechanisms navigating the TGF-β pathway in prostate cancer
by: Zheng Cao, et al.
Published: (2015-01-01)

The Promise of Novel Molecular Markers in Bladder Cancer
by: Jahan Miremami, et al.
Published: (2014-12-01)

Molecular Signatures in Urologic Tumors
by: Spencer Larkin, et al.
Published: (2013-09-01)

Coronavirus Disease in South Korea: Antibody Testing from the Perspective of Effective Quarantine Measures
by: Insuk Sim, et al.
Published: (2021-06-01)

Comparison of Four SARS-CoV-2 Neutralization Assays
by: Lydia Riepler, et al.
Published: (2021-12-01)

Realizing the Potential of Anti-SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management
by: Gandhi, R.T, et al.
Published: (2022)

Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2
by: Bianca A. Trombetta, et al.
Published: (2021-06-01)

Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS‑CoV‑2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients
by: Achala Kamaladasa, et al.
Published: (2021-08-01)

Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects
by: Franck P. Dupuy, et al.
Published: (2019-12-01)

Profiling Prostate Cancer Therapeutic Resistance
by: Cameron A. Wade, et al.
Published: (2018-03-01)

Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies
by: Sally Esmail, et al.
Published: (2021-06-01)

A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay
by: Gaetano Donofrio, et al.
Published: (2021-04-01)

Application value of SARS-CoV-2 IgG and IgM antibodies in diagnosis and treatment of new coronavirus pneumonia
by: HU Qianfang, et al.
Published: (2020-08-01)

Lack of MERS Coronavirus Neutralizing Antibodies in Humans, Eastern Province, Saudi Arabia
by: Stefanie Gierer, et al.
Published: (2013-12-01)

Prevalence and Incidence of Non-neutralizing Antibodies in Congenital Hemophilia A— A Systematic Review and Meta-Analysis
by: A. Abdi, et al.
Published: (2020-05-01)

Comparison of a Micro-Neutralization Test with the Rapid Fluorescent Focus Inhibition Test for Measuring Rabies Virus Neutralizing Antibodies
by: Todd G. Smith, et al.
Published: (2017-07-01)

Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination
by: Haya Altawalah
Published: (2021-08-01)

Inflammation as a Driver of Prostate Cancer Metastasis and Therapeutic Resistance
by: Maddison Archer, et al.
Published: (2020-10-01)

Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection
by: Hui-Ju Han, et al.
Published: (2018-11-01)

Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection
by: Arnaud John Kombe Kombe, et al.
Published: (2021-05-01)

An improved microtiter assay for evaluating anti-HIV-1 neutralizing antibodies from sera or plasma
by: Chen Yunyun, et al.
Published: (2003-12-01)

MSD-based assays facilitate a rapid and quantitative serostatus profiling for the presence of anti-AAV antibodies
by: Blazevic, D., et al.
Published: (2022)

Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2
by: Rocktotpal Konwarh, et al.
Published: (2020-06-01)

Neutralization Interfering Antibodies: A “Novel” Example of Humoral Immune Dysfunction Facilitating Viral Escape?
by: Roberto Burioni, et al.
Published: (2012-09-01)

Quantitative SARS-CoV-2 Spike Antibody Response in COVID-19 Patients Using Three Fully Automated Immunoassays and a Surrogate Virus Neutralization Test
by: Yoonjoo Kim, et al.
Published: (2021-08-01)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
by: Jiajia Xie, et al.
Published: (2021-08-01)

A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies
by: Meredith E. Davis-Gardner, et al.
Published: (2020-01-01)

Real-Time qPCR as a Method for Detection of Antibody-Neutralized Phage Particles
by: Anna Kłopot, et al.
Published: (2017-11-01)

Systemic Adverse Events and Use of Antipyretics Predict the Neutralizing Antibody Positivity Early after the First Dose of ChAdOx1 Coronavirus Disease Vaccine
by: Ji Young Park, et al.
Published: (2021-06-01)

Colloidal gold immunochromatographic assay (GICA) is an effective screening method for identifying detectable anti-SARS-CoV-2 neutralizing antibodies
by: Xinjie Li, et al.
Published: (2021-07-01)

BNT162b2 mRNA SARS-CoV-2 Vaccine Elicits High Avidity and Neutralizing Antibodies in Healthcare Workers
by: Federico Pratesi, et al.
Published: (2021-06-01)

Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
by: Gururaj Rao Deshpande, et al.
Published: (2020-01-01)

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
by: Gabriele Anichini, et al.
Published: (2021-05-01)

Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays
by: Jenni Virtanen, et al.
Published: (2021-05-01)

Challenges of Rabies Serology: Defining Context of Interpretation
by: Susan M. Moore
Published: (2021-07-01)

Development and clinical evaluation of a rapid antibody lateral flow assay for the diagnosis of SARS-CoV-2 infection
by: Kesheng Li, et al.
Published: (2021-08-01)